(Q40334629)

19 September 2017

title

No effect of rosuvastatin in the zoledronate-induced acute-phase response (English)

1 reference

19 September 2017

3

1 reference

19 September 2017

Polyzois Makras

1

0 references

author name string

Athanasios D Anastasilakis

2

1 reference

19 September 2017

Ilias Bisbinas

4

1 reference

19 September 2017

Grigorios T Sakellariou

5

1 reference

19 September 2017

Socrates E Papapoulos

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

9 February 2011

1 reference

Calcified Tissue International

19 September 2017

published in

1 reference

19 September 2017

volume

88

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

402-408

1 reference

Characterization of and risk factors for the acute-phase response after zoledronic acid

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Molecular mechanisms of action of bisphosphonates: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9468-2

10.1007/S00223-011-9468-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1030597776

0 references

1 reference